MicroRNA-directed pathway discovery elucidates an miR-221/222–mediated regulatory circuit in class switch recombination

Author:

Wigton Eric J.12ORCID,Mikami Yohei34ORCID,McMonigle Ryan J.5ORCID,Castellanos Carlos A.12ORCID,Wade-Vallance Adam K.167ORCID,Zhou Simon K.12ORCID,Kageyama Robin128ORCID,Litterman Adam12ORCID,Roy Suparna19ORCID,Kitamura Daisuke10ORCID,Dykhuizen Emily C.11ORCID,Allen Christopher D.C.167ORCID,Hu Hui5ORCID,O’Shea John J.3ORCID,Ansel K. Mark12ORCID

Affiliation:

1. Sandler Asthma Basic Research Center, University of California, San Francisco, San Francisco, CA

2. Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA

3. Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Rockville, MD

4. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

5. Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL

6. Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA

7. Department of Anatomy, University of California, San Francisco, San Francisco, CA

8. Parker Institute for Cancer Immunotherapy, San Francisco, CA

9. Department of Dermatology, University of California, San Francisco, San Francisco, CA

10. Research Institute for Biomedical Sciences, Tokyo University of Science, Chiba, Japan

11. Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN

Abstract

MicroRNAs (miRNAs, miRs) regulate cell fate decisions by post-transcriptionally tuning networks of mRNA targets. We used miRNA-directed pathway discovery to reveal a regulatory circuit that influences Ig class switch recombination (CSR). We developed a system to deplete mature, activated B cells of miRNAs, and performed a rescue screen that identified the miR-221/222 family as a positive regulator of CSR. Endogenous miR-221/222 regulated B cell CSR to IgE and IgG1 in vitro, and miR-221/222–deficient mice exhibited defective IgE production in allergic airway challenge and polyclonal B cell activation models in vivo. We combined comparative Ago2-HITS-CLIP and gene expression analyses to identify mRNAs bound and regulated by miR-221/222 in primary B cells. Interrogation of these putative direct targets uncovered functionally relevant downstream genes. Genetic depletion or pharmacological inhibition of Foxp1 and Arid1a confirmed their roles as key modulators of CSR to IgE and IgG1.

Funder

National Institutes of Health

Canadian Institutes of Health Research

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3